Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,160.00
+3.270.28%
Pre-market: 1,164.094.09+0.35%06:38 EDT
Volume:2.52M
Turnover:2.94B
Market Cap:1.10T
PE:38.94
High:1,188.33
Open:1,188.00
Low:1,156.85
Close:1,156.73
52wk High:1,292.65
52wk Low:712.05
Shares:945.38M
Float Shares:939.00M
Volume Ratio:0.94
T/O Rate:0.27%
Dividend:6.69
Dividend Rate:0.58%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:32.37
PE(LYR):50.54

Loading ...

Eli Lilly Long-Term GLP-1 Franchise Faces Limited Generic Threat, UBS Says

MT Newswires Live
·
Jul 17

7 Stocks that actually play defence: Jon Erlichman

Bloomberg
·
Jul 17

Eli Lilly’s $3.8 Billion Psychedelic Bet Could Reshape Neuroscience!

Smartkarma
·
Jul 17

AtaiBeckley (ATAI) Agrees To Eli Lilly Buyout With Milestone Upside For Shareholders

Simply Wall St.
·
Jul 17

PRESS Digest-british Business - July 17

Reuters
·
Jul 17

AtaiBeckley downgraded to Neutral from Buy at Guggenheim

TIPRANKS
·
Jul 17

Biotech M&A : Psychedelics' Coming as Eli Lilly's AtaiBeckley Acquisition Sets a Valuation Benchmark

Smartkarma
·
Jul 17

Eli Lilly Likely to See More Momentum in GLP-1 Pipeline, UBS Says

MT Newswires Live
·
Jul 17

AtaiBeckley downgraded to Hold from Buy at Maxim

TIPRANKS
·
Jul 17

Lilly’s Tersolisib Food-Effect Study Moves Forward, Adding Depth to Its Early-Stage Pipeline

TIPRANKS
·
Jul 17

Eli Lilly’s New Phase 1 Trial for LY4268989 Signals Fresh Pipeline Momentum

TIPRANKS
·
Jul 17

Deals of the Day-mergers and Acquisitions

Reuters
·
Jul 16

Meta, Vistra, T. Rowe Price and a Health Care Stock on CNBC’s ‘Final Trades’

Benzinga_recent_news
·
Jul 16

Ataibeckley Inc: Co to Pay Eli Lilly Termination Fee of $104.3 Mln if Deal Terminated Under Some Circumstances - SEC Filing

THOMSON REUTERS
·
Jul 16

Eli Lilly Expands Neuroscience Footprint with Ataibeckley Acquisition

Dow Jones
·
Jul 16

Eli Lilly Says Milestone Payments Boost Potential Value of Ataibeckley Deal

Dow Jones
·
Jul 16

Eli Lilly Says Clinical Trial Success Propels Ataibeckley Lead Program into Phase 3

Dow Jones
·
Jul 16

Eli Lilly to Acquire AtaiBeckley for $2.8 Billion in Cash, Up to $1 Billion in Milestone Payments

MT Newswires Live
·
Jul 16

Ataibeckley Shares Pare Gains After Eli Lilly to Acquire Co for up to $3.8 Bln, Last up 31% Premarket

THOMSON REUTERS
·
Jul 16

Lilly to Buy Ataibeckley for USD 6.75 Per Share Plus CVR up to USD 2.5

Reuters
·
Jul 16